Audentes Therapeutics Reports Third Death in a Clinical Trial
Audentes Therapeutics has reported a third death in a clinical trial of its gene therapy against a rare genetic neuromuscular…
Audentes Therapeutics has reported a third death in a clinical trial of its gene therapy against a rare genetic neuromuscular…